Communications

(Nov. 1, 2024) – As part of its efforts to mitigate the disruption to the supply of IV solutions after Hurricane Helene temporarily closed its North Cove, N.C., manufacturing plant, Baxter announced it is now authorized by the Food and Drug Administration to extend the use date of some products to provide a 24-month expiration from the manufacture date without relabeling the products. In a letter to customers, Baxter said the extended expiration date is based on Baxter's submission to the FDA, which includes container closure integrity data, container functional performance data and an analysis of product weight loss profiles for specific product codes. Please see the Baxter document that contains the complete list of Baxter product codes, lot/serial numbers, labeled expiration dates and extended expiration dates. The extended expiration dates apply only to product codes manufactured before Sept. 30, 2024.
--Ron Marshall